AQUESTIVE THERAPEUTICS
Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. Aquestive is committed to addressing immediate CNS challenges by furthering its strong pipeline of products. As the undisputed leader in developing and delivering drugs via its proprietary technologies, the Company also collaborates with pharmaceutical partners to bring new molecules to market in differentiated and highly-marketable dosage forms.
AQUESTIVE THERAPEUTICS
Industry:
Pharmaceutical
Founded:
2004-01-15
Address:
Warren, New Jersey, United States
Country:
United States
Website Url:
http://www.aquestive.com
Total Employee:
101+
Status:
Active
Contact:
908-941-1900
Email Addresses:
[email protected]
Total Funding:
368.06 M USD
Technology used in webpage:
Domain Not Resolving SPF Amazon Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS ASP.NET IIS IIS 10
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Immuneering
Immuneering is a bioinformatics company that develops new medicines unlikely to be found by traditional drug discovery methods.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Equity - Aquestive Therapeutics
Madryn Asset Management
Madryn Asset Management investment in Post-IPO Debt - Aquestive Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Debt Financing - Aquestive Therapeutics
Edward P. Bass Group
Edward P. Bass Group investment in Debt Financing - Aquestive Therapeutics
CNF Investments, LLC
CNF Investments, LLC investment in Debt Financing - Aquestive Therapeutics
Halifax Group
Halifax Group investment in Debt Financing - Aquestive Therapeutics
White Oak Global Advisors
White Oak Global Advisors investment in Debt Financing - Aquestive Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2023-06-29 | Aquestive Therapeutics Provides Business Update and Announces Chief Medical Officer Appointment |
Official Site Inspections
http://www.aquestive.com Semrush global rank: 5.15 M Semrush visits lastest month: 1.53 K
- Host name: cloudproxy10104.sucuri.net
- IP address: 192.124.249.104
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aquestive Therapeutics"
About Us | Aquestive Therapeutics
About Us Complex delivery, simplified. Aquestive Therapeutics, Inc. (NASDAQ: AQST) is a pharmaceutical company advancing medicines to bring meaningful improvement to patients' …See details»
Leadership - Aquestive
To subscribe to receive information updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check …See details»
Aquestive Therapeutics - Crunchbase Company Profile …
Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and …See details»
Aquestive Therapeutics Reports First Quarter 2025 Financial …
19 hours ago Submitted NDA for Anaphylm™ (epinephrine), the first and only oral sublingual film for patients with severe allergic reactions Advancing commercial readiness efforts with a …See details»
Q1 2025 Aquestive Therapeutics, Inc. Earnings Conference Call
6 hours ago The Investor Relations website contains information about Aquestive Therapeutics's business for stockholders, potential investors, and financial analysts.See details»
Aquestive Therapeutics Provides Business Update and Outlines …
Dec 31, 2024 WARREN, N.J., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing …See details»
Aquestive Therapeutics - Leadership Team | The Org
The Leadership Team at Aquestive Therapeutics is responsible for guiding the strategic direction of the company and overseeing the development and commercialization of specialty …See details»
Press Releases - Aquestive Therapeutics
Mar 5, 2025 The Investor Relations website contains information about Aquestive Therapeutics's business for stockholders, potential investors, and financial analysts.See details»
Earnings call transcript: Aquestive’s Q1 2025 earnings miss, stock ...
15 hours ago Full transcript - Aquestive Therapeutics Inc (AQST) Q1 2025: Conference Operator: Good day, and thank you for standing by. Welcome to the Aquestive Therapeutics …See details»
Aquestive Therapeutics, Inc. - AnnualReports.com
Aquestive Therapeutics is a pharmaceutical company that applies innovative technology to solve therapeutic problems and improve medicines for patients. Aquestive is advancing a late-stage proprietary product pipeline to treat CNS …See details»
Aquestive Therapeutics Inc Company Profile - Overview
Aquestive Therapeutics Inc (Aquestive) is a pharmaceutical company that primarily focuses on the development of orally administered products. Its products provide novel alternatives to …See details»
Our Responsibility - Aquestive
Our Responsibility Aquestive is committed to conducting our business with the highest ethical standards. The Company's commitment to ethics and good corporate citizenship is grounded …See details»
Aquestive Therapeutics Company Profile - Craft
Oct 29, 2024 Aquestive Therapeutics is a pharmaceutical company that is engaged in drug development using PharmFilm technology. Its products include Suboxone, a sublingual film …See details»
What is Aquestive? Company Culture, Mission, Values
Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical therapeutic problems and meaningfully improve …See details»
Aquestive Therapeutics to Report First Quarter 2025 Financial …
WARREN, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to …See details»
Aquestive Therapeutics Reports First Quarter 2025 Financial
16 hours ago Aquestive is advancing a late-stage proprietary product candidate for the treatment of severe allergic reactions, including anaphylaxis, and an early-stage epinephrine prodrug …See details»
Aquestive Therapeutics (AQST) Reports Q1 Earnings: What Key
18 hours ago While the top- and bottom-line numbers for Aquestive Therapeutics (AQST) give a sense of how the business performed in the quarter ended March 2025, it could be worth …See details»
Aquestive Therapeutics, Inc. - SEC.gov
Sep 27, 2024 Aquestive Therapeutics, Inc. (the “Company”) is furnishing this Current Report on Form 8-K in connection with the disclosure of information, in the form of an investor …See details»
Our Capabilities and Expertise - Aquestive
Collaborating with Aquestive Aquestive offers vertically integrated development and production capabilities, spanning product formulation to final product packaging. With expertise in …See details»
Aquestive Therapeutics Overview | SignalHire Company Profile
Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve …See details»